Chinese Data Of The Cftr Mutation: A Report From West China Hospital And Literature Review

Yanting Wang,Jinheng Liu,Xiaodong Yang,Hao Yan,Yonggang Zhang
2018-01-01
Abstract:Background and objective: Cystic fibrosis (CF) is a serious genetic disorder that is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Little is known about the genetic information of the CFTR mutation in the Chinese population. The objective of this study is to report a new CFTR mutation in a Chinese CF patient and describe the CFTR mutations and clinical manifestations of this group in China. Methods: We studied a 20-year-old Chinese CF patient and performed DNA sequencing of the CFTR gene. We also analyzed published data on CFTR mutations in the Chinese population. Results: After sequencing the CFTR gene, we identified two mutations of the CFTR gene in the CF patient: one was c.263T>G (p.L88X) in exon 3 from her father and the other one was c.2335C>T (p.Q779X) in exon 14 from her mother. We found c.2335C>T to be a possible novel mutation. After we reviewed all the reported mutations in the Chinese CF patients, we found that nearly half of the reported mutations were located on splice junction sites and vary in their frequency and distribution from Caucasian groups. Conclusions: The current study reported a novel CFTR mutation in the Chinese CF patient. There is an urgent need to understand the mutation spectrum in China in order to establish a mutation panel for providing patients with earlier and more comprehensive treatment and genetic counseling.
What problem does this paper attempt to address?